Abstract
Since the COVID-19 pandemic, wastewater-based epidemiology (WBE) has emerged as a useful additional diagnostic tool for public health management. For rapid reporting of results and an automated implementation of WBE as a monitoring tool, a digital work flow of data is crucial. Here, we present the Automated Network for Normalization, Analysis, and Visualization of Wastewater and Environmental Surveillance (ANNA-WES); a comprehensive workflow integrating GIS-based data entry, Python-driven data processing, and ArcGIS-supported visualization. ANNA-WES streamlines data transfer between wastewater treatment plant operators, decision-makers, and the public while ensuring harmonized data processing for transferability, precise georeferencing of index cases, and near real-time SARS-CoV-2 biomarker reporting. To enhance data reliability, we embedded an unsupervised quality control algorithm that filters outliers based on gene ratios, surrogate viruses, water quality parameters, and theoretical reproductive value thresholds. Designed for scalability, ANNA-WES integrates into public dashboards and can be combined with regional or national health data, providing a robust decision-support system for infectious disease surveillance. The workflow is adaptable to various pathogens or biomarkers, advancing WBE as a continuous, quality-controlled public health monitoring tool.
Competing Interest Statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Esri Deutschland GmbH , represented by Mr. Ingo Michels, worked as a subcontractor for TUM.
Funding Statement
This study was financially supported by the German Federal Ministry of Education and Research as part of the funding program Sustainable Water Management (NaWaM-RiSKWa) (Biomarker, grant number 02WRS1557) and the Bavarian State Ministry of Health and Care (StMGP). Additional funding was provided through the AMELAG project, funded by the German Federal Ministry of Health (BMG). A. G. received funding the Bay-VOC project, funded by the StMGP. I.M. was a subcontractor by PTKA. C.Wb. was financed by DFG WU 890/2-1.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos